2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action
- 9 October 2003
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 66 (11) , 2169-2176
- https://doi.org/10.1016/j.bcp.2003.08.005
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failureCardiovascular Research, 2002
- Inotropic Activity of Hydroindene AmidinohydrazonesJournal of Medicinal Chemistry, 2001
- Synthesis and Inotropic Activity of 1-(O-Aminoalkyloximes) of Perhydroindene Derivatives as Simplified Digitalis-like Compounds Acting on the Na+,K+-ATPaseJournal of Medicinal Chemistry, 2001
- 17α-O-(Aminoalkyl)oxime Derivatives of 3β,14β-Dihydroxy-5β-androstane and 3β-Hydroxy-14-oxoseco-D-5β-androstane as Inhibitors of Na+,K+-ATPase at the Digitalis ReceptorJournal of Medicinal Chemistry, 2001
- Synthesis and preliminary pharmacological evaluation of coumestans with different patterns of oxygenationBioorganic & Medicinal Chemistry Letters, 2001
- Can physicians always explain the results of clinical trials? a case study of amlodipine in heart failureThe American Journal of Cardiology, 1999
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997
- Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trialJournal of the American College of Cardiology, 1993
- Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme InhibitorsNew England Journal of Medicine, 1993
- Über die Identität der Ionenpumpen-ATPase in der Zellmembran des Herzmuskels mit einem Digitalis-RezeptorenzymCellular and Molecular Life Sciences, 1963